User profiles for Jordi Camps

Jordi Camps Andreu

Coordinator, Research Laboratory, Hospital Universitari de Sant Joan, Reus, Spain.
Verified email at grupsagessa.com
Cited by 13156

The paraoxonases: role in human diseases and methodological difficulties in measurement

J Camps, J Marsillach, J Joven - Critical reviews in clinical …, 2009 - Taylor & Francis
Research into the paraoxonase (PON) gene family has flourished over the past few years.
In the 1970s and 1980s, only PON1 was known, and the investigations were conducted, …

[HTML][HTML] Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities

…, M Riera-Borrull, F Luciano-Mateo, J Camps… - Mediators of …, 2013 - hindawi.com
Obesity is not necessarily a predisposing factor for disease. It is the handling of fat and/or
excessive energy intake that encompasses the linkage of inflammation, oxidation, and …

[HTML][HTML] Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism

A Rull, J Camps, C Alonso-Villaverde… - Mediators of …, 2010 - hindawi.com
To maintain homeostasis under diverse metabolic conditions, it is necessary to coordinate
nutrient-sensing pathways with the immune response. This coordination requires a complex …

[HTML][HTML] First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain

…, N Sabaté, A Teixidó, C Vasco, J Camps… - PloS one, 2021 - journals.plos.org
Many countries have seen a two-wave pattern in reported cases of coronavirus disease-19
during the 2020 pandemic, with a first wave during spring followed by the current second …

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: results of a randomized study

…, F Bory, J Cabrera, A Rimola, J Viver, J Camps… - Gastroenterology, 1987 - Elsevier
To investigate whether paracentesis could be an alternative therapy for ascites, 117 cirrhotics
with tense ascites were randomly allocated into two groups. Fifty-eight patients (group 1) …

[PDF][PDF] AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations

…, S Bunting, N Feldhahn, A Bothmer, J Camps… - Molecular cell, 2009 - cell.com
Cancer-initiating translocations such as those associated with lymphomas require the formation
of paired DNA double-strand breaks (DSBs). Activation-induced cytidine deaminase (AID…

Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage

N Ferré, J Camps, E Prats, E Vilella, A Paul… - Clinical …, 2002 - academic.oup.com
Background: Paraoxonase 1 (PON1) is an ester hydrolase present in serum and in the liver.
The aims of the present study were to investigate the following: (a) the relationship between …

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

…, M De La Mata, L Lupo, S Strasser, JW Park, J Camps… - Gut, 2019 - gut.bmj.com
Objective Sorafenib is the standard systemic therapy for advanced hepatocellular carcinoma
(HCC). Survival benefits of resection/local ablation for early HCC are compromised by 70% …

A consensus view of protein dynamics

…, T Meyer, A Pérez, J Camps… - Proceedings of the …, 2007 - National Acad Sciences
The dynamics of proteins in aqueous solution has been investigated through a massive
approach based on “state of the art” molecular dynamics simulations performed for all protein …

Mutated KRAS results in overexpression of DUSP4, a MAP‐kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas

J Gaedcke, M Grade, K Jung, J Camps… - Genes …, 2010 - Wiley Online Library
Mutations of the KRAS oncogene are predictive for resistance to treatment with antibodies
against the epithelial growth factor receptor in patients with colorectal cancer. Overcoming this …